Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans. When tested in rodents, the vaccine elicited a strong immune response and prevented infections in animals exposed to H5N1.
Nasal vaccine combats bird flu infection in rodents
View Content